Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00217) | |||||
---|---|---|---|---|---|
Name |
Dronabinol
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
Dronabinol; TETRAHYDROCANNABINOL; Marinol; delta9-Tetrahydrocannabinol; delta9-THC; delta-9-tetrahydrocannabinol; Deltanyne; Abbott 40566; delta-9-THC; delta(9)-THC; delta1-THC; Dronabinolum; delta(1)-Tetrahydrocannabinol; delta(9)-Tetrahydrocannabinol; 1-trans-delta-9-Tetrahydrocannabinol; delta(sup 1)-Thc; delta(sup 9)-Thc; Namisol; (-)-delta9-trans-Tetrahydrocannabinol; 9-tetrahydrocannabinol; QCD 84924; SP 104; delta1-Tetrahydrocannabinol; 1-trans-delta9-Tetrahydrocannabinol; delta(9)-Tetrahydrocannibinol; QCD-84924; Syndros; delta(sup 1)-Tetrahydrocannabinol; delta(sup 9)-Tetrahydrocannabinol; L-delta1-trans-Tetrahydrocannabinol; Cannabinol, delta1-tetrahydro-; CCRIS 4726; CHEBI:66964; 3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,d)pyran-1-ol; CHEMBL465; Tetrahydrocannabinols (-)-delta1-3,4-trans-form; (6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol; UNII-7J8897W37S; Cannabinol, 1-trans-delta(sup 9)-tetrahydro-; 6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol; 7J8897W37S; NSC-134454; Dronabinolum [Latin]; Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol; 6,6,9-Trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-dibenzo(b,d)pyran-1-ol; .DELTA.9-Tetrahydrocannabinol; (-)-.DELTA.9-THC; Compassia; Relivar; (L)-.delta.1-Tetrahydrocannabinol; (-)-.DELTA.1-Tetrahydrocannabinol; (-)-.DELTA.9-Tetrahydrocannabinol; L-.delta.1-trans-Tetrahydrocannabinol; L-trans-.delta.9-Tetrahydrocannabinol; (-)-.DELTA.9-trans-Tetrahydrocannabinol; (-)-trans-.DELTA.9-Tetrahydrocannabinol; Marinol (TN); DEA No. 7369; .DELTA.1-THC; .DELTA.9-THC; delta1-Tetrahydrocannabinol (VAN); delta9-Tetrahydrocannabinol (VAN); Dronabinol (USP/INN); .DELTA.1-Tetrahydrocannabinol; Tetrahydrocannabinol delta9; (-)-trans-Delta9-THC; (l)-delta(sup 1)-Tetrahydrocannabinol; Cannabinol, .DELTA.1-tetrahydro-; 1-trans-delta(sup 9)-Tetrahydrocannabinol; .DELTA.9-trans-Tetrahydrocannabinol; (l)-delta1-Tetrahydrocannabinol; L-.delta.1-Tetrahydrocannabinol; (-)-delta1-Tetrahydrocannabinol; (-)-delta9-Tetrahydrocannabinol; delta9-trans-Tetrahydrocannabinol; HSDB 6471; trans-delta9-Tetrahydrocannabinol; CAT-310; L-trans-delta9-Tetrahydrocannabinol; (-)-delta(sup 1)-3,4-trans-Tetrahydrocannabinol; DRG-0138; 14C-.DELTA.1-Tetrahydrocannabinol; trans-.DELTA.9-Tetrahydrocannabinol; (-)-trans-Delta1-Tetrahydrocannabinol; (-)-trans-delta9-Tetrahydrocannabinol; NSC 134454; .delta.-9-THC; 1-trans-delta(sup9)-tetrahydrocannabinol; .delta.(sup9)-THC; (-)-3,4-trans-Delta1-Tetrahydrocannabinol; 1-trans-.delta.(sup9)-tetrahydrocannabinol; DSSTox_CID_1327; (-)-.delta.(sup9)-trans-Tetrahydrocannabinol; Epitope ID:224552; Marinol,Tetrahydrocannabinol; SCHEMBL4609; delta 9-Tetrahydrocannabinol; delta-9 Tetrahydrocannabinol; DSSTox_RID_76083; trans-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol; DSSTox_GSID_21327; BIDD:GT0427; Dronabinol [USAN:USP:INN]; ABBOTT-40566; GTPL2424; Cannabinol, tetrahydro- (6CI); DTXSID6021327; BDBM60994; US9416103, Delta9-THC; INT-0010; ZINC1530625; Tox21_112616; BDBM50007391; NSC134454; PDSP2_000714; SP-104; Cannabinol, Delta1-tetrahydro- (7CI); DB00470; INT-0010/06; (-)-Delta9-Tetrahydrocannabinol solution; 6465-30-1; CAS-1972-08-3; Synthetic THC in sesame oil / soft gelatin; C06972; Cannabinol, 1-trans-.delta.(sup9)-tetrahydro-; D00306; Tetrahydrocannabinols (-)-trans-.delta.9-form; 23623-EP2269989A1; 23623-EP2275420A1; 23623-EP2298764A1; 23623-EP2298765A1; 23623-EP2298772A1; 23623-EP2308839A1; 23623-EP2314298A1; 23623-EP2314580A1; Dronabinol in sesame oil in soft gelatin capsule; 124699-EP2272825A2; 124699-EP2289509A2; 124699-EP2295426A1; 124699-EP2295427A1; 148820-EP2289509A2; Q190067; (-)-Delta9-THC (Dronabinol) 0.1 mg/ml in Methanol; (-)-Delta9-THC (Dronabinol) 1.0 mg/ml in Methanol; (-)-Delta9-THC (Dronabinol) 5.0 mg/ml in Methanol; Delta9-Tetrahydrocannabinol solution, ethanol solution; UNII-K4H93P747O component CYQFCXCEBYINGO-IAGOWNOFSA-N; 6H-Dibenzo[b, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-; (-)-Delta9-Tetrahydrocannabinol (Delta9-THC) 100 microg/mL in Methanol; (-)-Delta9-Tetrahydrocannabinol (Delta9-THC) 1000 microg/mL in Methanol; 6,9-Trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-ol; 6H-Dibenzo[b, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, trans-; (6AR,10AR)-6,6,9-TRIMETHYL-3-PENTYL-6H,6AH,7H,8H,10AH-BENZO[C]ISOCHROMEN-1-OL; (S)-6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol; 6H-Dibenzo[b, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Anorexia nervosa | ICD-11: 6B80 | [1] | ||
PubChem CID | |||||
Formula |
C21H30O2
|
||||
Canonical SMILES |
CCCCCC1=CC(=C2[C@@H]3C=C(CC[C@H]3C(OC2=C1)(C)C)C)O
|
||||
InChI |
1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1
|
||||
InChIKey |
CYQFCXCEBYINGO-IAGOWNOFSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=16078"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 314.5 | Topological Polar Surface Area | 29.5 | |
XlogP | 7 | Complexity | 439 | ||
Heavy Atom Count | 23 | Rotatable Bond Count | 4 | ||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Dronabinol 5 mg capsule | Click to Show/Hide the Full List of Formulation(s): 7 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c yellow no. 6; Isopropyl alcohol; Ammonia; Glycerin; Propylene glycol; Titanium dioxide; Water; Silicon dioxide; Dimethicone; Gelatin; Sesame oil; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Akorn | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c yellow no. 6; Isopropyl alcohol; Ammonia; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Water; Gelatin; Sesame oil; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | American Health Packaging; Par Pharmaceutical; Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c yellow no. 6; Isopropyl alcohol; Ammonia; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Water; Gelatin, unspecified; Sesame oil; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Major Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Isopropyl alcohol; Ammonia; Ferric oxide red; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Water; Gelatin; Polyethylene glycols; Polyvinyl acetate phthalate; Sesame oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide red; Ferrosoferric oxide; Glycerin; Titanium dioxide; Gelatin; Sesame oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Physicians Total Care | |||||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide red; Ferrosoferric oxide; Glycerin; Titanium dioxide; Gelatin, unspecified; Sesame oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | AbbVie; Ascend Laboratories | |||||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide red; Ferrosoferric oxide; Glycerin; Titanium dioxide; Gelatin, unspecified; Sesame oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Actavis Pharma | |||||
Dronabinol 2.5 mg capsule | Click to Show/Hide the Full List of Formulation(s): 8 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c yellow no. 6; Isopropyl alcohol; Ammonia; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Water; Gelatin; Sesame oil; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Par Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c yellow no. 6; Isopropyl alcohol; Ammonia; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Water; Gelatin; Sesame oil; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | American Health Packaging | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c yellow no. 6; Isopropyl alcohol; Ammonia; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Water; Gelatin, unspecified; Sesame oil; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Major Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Isopropyl alcohol; Ammonia; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Water; Gelatin; Sesame oil; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Akorn | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Isopropyl alcohol; Ammonia; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Water; Gelatin; Polyethylene glycols; Polyvinyl acetate phthalate; Sesame oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Glycerin; Titanium dioxide; Gelatin; Sesame oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Physicians Total Care | |||||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Glycerin; Titanium dioxide; Gelatin, unspecified; Sesame oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Ascend Laboratories | |||||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Glycerin; Titanium dioxide; Gelatin, unspecified; Sesame oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Actavis Pharma | |||||
Dronabinol 10 mg capsule | Click to Show/Hide the Full List of Formulation(s): 5 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Butyl alcohol; Fd&c yellow no. 6; Isopropyl alcohol; Ammonia; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Water; Gelatin; Sesame oil; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Par Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Butyl alcohol; Fd&c yellow no. 6; Isopropyl alcohol; Ammonia; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Water; Gelatin; Sesame oil; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Akorn | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Isopropyl alcohol; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Water; Gelatin; Polyethylene glycols; Polyvinyl acetate phthalate; Sesame oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide red; Ferric oxide yellow; Glycerin; Titanium dioxide; Gelatin, unspecified; Sesame oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | AbbVie; Ascend Laboratories | |||||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide red; Ferric oxide yellow; Glycerin; Titanium dioxide; Gelatin, unspecified; Sesame oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Actavis Pharma | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.